Nebivolol, a β-blocker abrogates streptozotocin-induced behavioral, biochemical, and neurophysiological deficit by attenuating oxidative-nitrosative stress: a possible target for the prevention of diabetic neuropathy - Bhadri, N; Razdan, R; Goswami, S K (Naunyn Schmiedebergs Arch Pharmacol., 2018)
Feb